Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) have been given an average recommendation of “Buy” by the seven brokerages that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and four have assigned a strong buy rating to the company.
RBGLY has been the subject of several analyst reports. HSBC upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Sanford C. Bernstein downgraded Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Barclays raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th.
Get Our Latest Report on RBGLY
Reckitt Benckiser Group Stock Performance
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- 3 Dividend Kings To Consider
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Insider Buying Explained: What Investors Need to Know
- What Does the Future Hold for Eli Lilly?
- How Can Investors Benefit From After-Hours Trading
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.